New combo approach for Lung-Limited colorectal cancer shows promise in early trial

NCT ID NCT03599752

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase 2 trial studies whether combining chemotherapy with surgery to remove lung tumors works better than either treatment alone for patients with colorectal cancer that has spread only to the lungs. About 40 participants will be grouped by risk level to see if the combination improves survival or delays cancer return. The goal is to find the best treatment plan for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma colorectal cancer colorectal carcinoma colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Colllege of Medicine

    Houston, Texas, 77030, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • University Health Network Princess Margaret Cancer Center P2C

    Toronto, Ontario, M5G 2M9, Canada

  • University of Montreal

    Montreal, Quebec, H3T 1J7, Canada

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States